Evidence map›Paper›PMID 24841265›Full record

Trial reportAntimicrobial agents and chemotherapy2014

Prevalence of chlorhexidine-resistant methicillin-resistant Staphylococcus aureus following prolonged exposure.

Carey D Schlett, Eugene V Millar, Katrina B Crawford, Tianyuan Cui, Jeffrey B Lanier, David R Tribble, Michael W Ellis

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 67 citations in OpenAlex.

  1. Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.Journal of the American Society of Nephrology : JASN · 2018
    Trial
  2. Trial
  3. Article
  4. Article
  5. Chlorhexidine 0.02% treatment for refractory blepharoconjunctivitis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  6. Colonization with antiseptic tolerantInfection control and hospital epidemiology · 2025
    Article
  7. NosocomialInternational journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Increasing usage of chlorhexidine in health care settings: blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Review
  12. A Comparison of the Adaptive Response ofFrontiers in microbiology · 2022
    Article
  13. Article
  14. Assessing the Potential for Unintended Microbial Consequences of Routine Chlorhexidine Bathing for Prevention of Healthcare-associated Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Review
  15. Impact of formulary interventions on the minimum inhibitory concentration of methicillin-resistant Staphylococcus aureus to mupirocin, chlorhexidine, and octenidine in a Singapore tertiary institution.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  16. Review
  17. Article
  18. Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistantProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Carey D SchlettInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biometrics, Uniformed Services University, Bethesda, Maryland, USA cschlett@idcrp.org.
Eugene V MillarInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biometrics, Uniformed Services University, Bethesda, Maryland, USA.
Katrina B CrawfordInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biometrics, Uniformed Services University, Bethesda, Maryland, USA.
Tianyuan CuiInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biometrics, Uniformed Services University, Bethesda, Maryland, USA.
Jeffrey B LanierMartin Army Community Hospital, Fort Benning, Georgia, USA.
David R TribbleInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biometrics, Uniformed Services University, Bethesda, Maryland, USA.
Michael W EllisDepartment of Medicine, Uniformed Services University, Bethesda, Maryland, USA.
Uniformed Services University of the Health Sciences · USCommunity Hospital · US

Funding

DATA CENTER FOR EPIDEMIOLOGIC INVESTIGATIONS OF HIVN01AI005072 · NIAID · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI MCKINLAY, SONJA M · 1990 to 1994
–
NIAID NIH HHS Y01 AI005072NIAID NIH HHS Y1-AI-5072
6 · The paper itself

Abstract

Chlorhexidine has been increasingly utilized in outpatient settings to control methicillin-resistant Staphylococcus aureus (MRSA) outbreaks and as a component of programs for MRSA decolonization and prevention of skin and soft-tissue infections (SSTIs). The objective of this study was to determine the prevalence of chlorhexidine resistance in clinical and colonizing MRSA isolates obtained in the context of a community-based cluster-randomized controlled trial for SSTI prevention, during which 10,030 soldiers were issued chlorhexidine for body washing. We obtained epidemiological data on study participants and performed molecular analysis of MRSA isolates, including PCR assays for determinants of chlorhexidine resistance and high-level mupirocin resistance and pulsed-field gel electrophoresis (PFGE). During the study period, May 2010 to January 2012, we identified 720 MRSA isolates, of which 615 (85.4%) were available for molecular analysis, i.e., 341 clinical and 274 colonizing isolates. Overall, only 10 (1.6%) of 615 isolates were chlorhexidine resistant, including three from the chlorhexidine group and seven from nonchlorhexidine groups (P > 0.99). Five (1.5%) of the 341 clinical isolates and five (1.8%) of the 274 colonizing isolates harbored chlorhexidine resistance genes, and four (40%) of the 10 possessed genetic determinants for mupirocin resistance. All chlorhexidine-resistant isolates were USA300. The overall prevalence of chlorhexidine resistance in MRSA isolates obtained from our study participants was low. We found no association between extended chlorhexidine use and the prevalence of chlorhexidine-resistant MRSA isolates; however, continued surveillance is warranted, as this agent continues to be utilized for infection control and prevention efforts.

Indexed as

Genes, BacterialAdolescentAdultAnti-Infective Agents, LocalBacterial Typing TechniquesChlorhexidineDrug Resistance, BacterialElectrophoresis, Gel, Pulsed-FieldHand DisinfectionHumansMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMilitary PersonnelMupirocinStaphylococcal InfectionsAnti-Infective Agents, LocalChlorhexidineMupirocin

Identifiers

PMID24841265
PMCPMC4136006
OpenAlexW2144090352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.